SAB Biotherapeutics says its genetically engineered cows show the same immune response as survivors of disease such as COVID-19. / Donal O' Leary
ADVERTISEMENT
Genetically engineered cows are being used in an American trial to develop a virus against COVID-19.
SAB Biotherapeutics says its genetically engineered cows show the same immune response as survivors of diseases such as COVID-19.
It says testing on cows could speed up the process of delivering a vaccine as it would eliminate the need to identify, screen and draw blood from recovering human volunteers.
ADVERTISEMENT
“As a ruminant, cows inherently have a more robust immune response than humans. This response is stimulated when an immunogen specifically and exclusively targeted to a virus, such as SARS-CoV-2, is introduced, activating the entire disease fighting force of human antibodies,” SAB Biotherapeutics said.
“We further boost the response with a specialised vaccine formulation and strategy that maintains a high level of antibody production over an extended period of time and targets plasma collection at the highest levels.”
The company said there were many benefits to using cows in a trial. It said that cows could be injected with a non-infectious subunit and produce antibodies to the immunogen without becoming infected or getting sick.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Genetically engineered cows are being used in an American trial to develop a virus against COVID-19.
SAB Biotherapeutics says its genetically engineered cows show the same immune response as survivors of diseases such as COVID-19.
It says testing on cows could speed up the process of delivering a vaccine as it would eliminate the need to identify, screen and draw blood from recovering human volunteers.
“As a ruminant, cows inherently have a more robust immune response than humans. This response is stimulated when an immunogen specifically and exclusively targeted to a virus, such as SARS-CoV-2, is introduced, activating the entire disease fighting force of human antibodies,” SAB Biotherapeutics said.
“We further boost the response with a specialised vaccine formulation and strategy that maintains a high level of antibody production over an extended period of time and targets plasma collection at the highest levels.”
The company said there were many benefits to using cows in a trial. It said that cows could be injected with a non-infectious subunit and produce antibodies to the immunogen without becoming infected or getting sick.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS